Addition of Dulaglutide or Empagliflozin to Standard-of-Care Treatment: Effect on Liver Steatosis in Patients With Type 2 Diabetes Mellitus

Emmanouil Koullias(National and Kapodistrian University of Athens), John Koskinas(National and Kapodistrian University of Athens), Melanie Deutsch(National and Kapodistrian University of Athens), Stavros Athanasopoulos(Therapeutic Health Services), Asimina Mitrakou(Alexandra Hospital), P.S. Zoumpoulis, Maria Papavdi(National and Kapodistrian University of Athens), E.K. Manesis(Therapeutic Health Services), Anastasia Thanopoulou(National and Kapodistrian University of Athens)
Cureus
February 7, 2024
Cited by 4


Related Papers